Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
neomycin til topikal anvendelse |
Is a |
Product containing neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Is a |
Product containing framycetin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Is a |
Product containing neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
neomycin til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin (substance) |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiinfektiøst middel til huden |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Is a |
antibiotikum til huden |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Has manufactured dose form |
kutan OG/ELLER transdermal doseringsform |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Is a |
Topical antibacterial |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Has manufactured dose form |
Cutaneous dose form |
false |
Inferred relationship |
Some |
|
|
neomycin til topikal anvendelse |
Is a |
Product manufactured as cutaneous dose form (product) |
false |
Inferred relationship |
Some |
|
|
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Neomycin sulfate 5 mg/mL eye drops |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
neomycinsulfat 0,5 % øjendråber til engangsbrug |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Neomycin sulfate 5 mg/g eye ointment |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Neomycin 0.5% cream BPC |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Neomycin 5 mg/g cutaneous ointment |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
neomycinsulfatpræparat til oftalmisk anvendelse |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
neomycinsulfat, opløsning til anvendelse i øre |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Neomycin ear drops |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Neomycin ear ointment |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
neomycin 0,5 % + hydrocortison 1,5 % øredråber |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
neomycin + hydrocortison 0,5 %/1,5 % øjen-/øredråber |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
bacitracinzink 400 enheder + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
bacitracinzink 500 enheder + polymyxin B-sulfat 10.000 enheder salve |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
dexamethason 1 mg + neomycinsulfat 3,5 mg salve |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
gramicidin 0,025 mg + neomycinsulfat 1,75 mg + polymyxin B-sulfat 10.000 enheder opløsning |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/10.000 opløsning |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
hydrocortisonacetat 5 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder creme |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
neomycinsulfat + polymyxin B-sulfat + prednisolonacetat 0,35 %/10.000 enheder/0,5 % wt/vol suspension |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing framycetin (medicinal product) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing fluocinolone and neomycin (medicinal product) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
clobetasonbutyrat + neomycinsulfat |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
clobetasolpropionat + neomycinsulfat + nystatin |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing methylprednisolone and neomycin (medicinal product) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing chlorhexidine and neomycin (medicinal product) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing bacitracin and neomycin and polymyxin B and pramocaine (medicinal product) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing clobetasol and neomycin and nystatin in topical dosage form |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
Is a |
False |
neomycin til topikal anvendelse |
Inferred relationship |
Some |
|